Route of progesterone administration for luteal phase support may affect outcome of controlled ovarian hyperstimulation for IVF with ICSI using GnRH antagonist

被引：0
|
作者：
Mustafa Bahceci
Ulun Ulug
机构：
[1] Bahceci Women Health Care Center,
[2] Bahceci Women Health Care Center and German Hospital in Istanbul,undefined
来源：
Journal of Assisted Reproduction and Genetics | 2008年 / 25卷
关键词：
Progesterone; Vaginal; Intramuscular; IVF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：499 / 502
页数：3
相关论文
共 50 条
  • [21] Timing of human chorionic gonadotropin trigger, in patients undergoing controlled ovarian hyperstimulation for IVF, using the GnRH antagonist protocol
    Orvieto, Raoul
    HUMAN FERTILITY, 2012, 15 (04) : 221 - 221
  • [22] Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles
    Toftager, M.
    Bogstad, J.
    Bryndorf, T.
    Lossl, K.
    Roskaer, J.
    Holland, T.
    Praetorius, L.
    Zedeler, A.
    Nilas, L.
    Pinborg, A.
    HUMAN REPRODUCTION, 2016, 31 (06) : 1253 - 1264
  • [23] Clinical Comparison of Ovarian Stimulation and Luteal Support Agents in Patients Undergoing GnRH Antagonist IVF Cycles
    Miller, Charles E.
    Zbella, Edward
    Webster, Bobby W.
    Doody, Kevin J.
    Bush, Mark R.
    Collins, Michael G.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2013, 58 (3-4) : 153 - 160
  • [24] Subcutaneous progesterone (Prolutex) versus vaginal (Cyclogest) for luteal phase support in IVF/ICSI cycles: a randomized controlled clinical trial
    Ashraf Moini
    Arezoo Arabipoor
    Zahra Zolfaghari
    Maria Sadeghi
    Fariba Ramezanali
    Middle East Fertility Society Journal, 27
  • [25] Subcutaneous progesterone (Prolutex) versus vaginal (Cyclogest) for luteal phase support in IVF/ICSI cycles: a randomized controlled clinical trial
    Moini, Ashraf
    Arabipoor, Arezoo
    Zolfaghari, Zahra
    Sadeghi, Maria
    Ramezanali, Fariba
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2022, 27 (01)
  • [26] Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial
    Fatemi, H. M.
    Kolibianakis, E. M.
    Camus, M.
    Tournaye, H.
    Donoso, P.
    Papanikolaou, E.
    Devroey, P.
    HUMAN REPRODUCTION, 2006, 21 (10) : 2628 - 2632
  • [27] Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of GnRH agonist vs. antagonist.
    Boostanfar, R
    Slater, C
    Klumph, S
    Saadat, P
    Tourgeman, D
    Paulson, RJ
    FERTILITY AND STERILITY, 2002, 77 (04) : S10 - S10
  • [28] The efficacy of modified luteal phase support with intramuscular progesterone in IVF/ICSI cycles: a retrospective observational study
    Conforti, A.
    Strina, I.
    Mollo, A.
    Amoroso, R.
    Marrone, V.
    Alviggi, C.
    Marci, R.
    De Placido, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (04) : 657 - 661
  • [29] Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles
    Sergio Oehninger
    Scott M. Nelson
    Pierre Verweij
    Barbara J. Stegmann
    Reproductive Biology and Endocrinology, 13
  • [30] Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles
    Oehninger, Sergio
    Nelson, Scott M.
    Verweij, Pierre
    Stegmann, Barbara J.
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2015, 13
12345